Purisys is a US-based CDMO specializing in custom Active Pharmaceutical Ingredients (APIs) and chemical synthesis projects, with over 40 years of commercial pharmaceutical production experience. The company is a global leader in pharmaceutical-grade cannabinoids and psychedelic compounds, with DEA-secure manufacturing capabilities. Purisys also offers reference standard synthesis and qualification with over 300 commercial standards. The company was recently acquired by Siegfried alongside Noramco.
custom API development and manufacturing, pharmaceutical-grade cannabinoid synthesis, psychedelic compound production, DEA-controlled substance manufacturing, reference standard synthesis
1 site worldwide
No reviews available yet.
No documents available.